Physician profile
Andrew James Clair
NPI 1265811400
$5,119.62
in general payments reported to CMS, 2019-2025
18 companies · $1,501 in 2025
The $1,501 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $871 · 2022: $637 · 2023: $466 · 2024: $1,646 · 2025: $1,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,126 · Travel and Lodging: $419 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,126.48 |
| Travel and Lodging | $418.79 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,480.12 | 2021-2025 | Real Intelligence, Journey II, Ri Hip Navigation |
| Stryker Corporation | $1,385.50 | 2021-2025 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $1,010.32 | 2022-2025 | Oxford, Avenir, Oxford Partial Knee |
| Medical Device Business Services, INC. | $272.82 | 2021-2025 | Velys |
| Next Science LLC | $254.73 | 2021-2024 | Blastx, Surgx, Xperience |
| Depuy Synthes Sales INC. | $239.13 | 2022-2025 | Actis |
| Medacta USA, INC. | $113.70 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $69.13 | 2025 | Exparel |
| Heron Therapeutics, INC. | $51.18 | 2025 | Zynrelef |
| Curonix LLC | $41.48 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Theragen, INC. | $41.07 | 2023-2025 | Kneehab Xp, Actastim-S |
| Kci USA, INC. | $28.23 | 2021-2023 | Prevena |
| Davol INC. | $26.76 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $26.24 | 2025 | |
| Convatec INC. | $22.70 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $22.05 | 2023 | Euflexxa |
| Sanara Medtech INC. | $17.50 | 2025 | Celleraterx |
| Guard Medical INC. | $16.96 | 2025 | Npseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Clair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.